Intensified radiation for older adults with glioblastoma
Part of Cancer clinical trials.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older
- You have been diagnosed with a type of brain tumor called glioblastoma (IDH-wildtype) within the last 8 weeks
- You are in good enough health to carry out daily activities (ECOG score 0-2)
- Your kidney, liver, and blood counts are within certain limits based on blood tests
- You have not had radiation or certain cancer treatments to the head or neck before
- You can have MRI scans with contrast dye (gadolinium) and do not have any serious active infections or other major medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial is testing a new way to deliver radiation therapy to a smaller area of the brain after surgery for glioblastoma. The goal is to see if this more focused approach can treat the tumor effectively while possibly reducing side effects and protecting healthy brain tissue.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma, a type of brain cancer. The goal is to see if this approach is effective and safe for patients under 70 who are otherwise in good health.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.